Skip to content

Comparison of khadiradi vati and AMC/DCBA throat lozenges in Ekvrinda (Acute pharyngitis)

A Randomized controlled trial to compare the effectiveness of khadiradi vati and Amylmetacresol/Dichlorobenzyl Alcohol(AMC/DCBA) throat lozenges in Ekvrinda W.S.R to Acute Pharyngitis - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088818
Enrollment
56
Registered
2025-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J029- Acute pharyngitis, unspecified

Interventions

None listed

Sponsors

Shri Ayurved Mahavidyalay Nagpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients which shows symptoms of Ekvrinda 2.Patients of age group 18-60 years 3.Patients irrespective of sex,educational status,socio-economic status,caste etc will be selected

Exclusion criteria

Exclusion criteria: 1.Patients with lower respiratory tract infections 2.Patients suffering with rhinitis 3.Patients with fever 4.Patients with recurrent or chronic pharyngitis 5.Any other major systemic disease

Design outcomes

Primary

MeasureTime frame
Releiving in symptoms of Ekvrinda 1.Galakandu 2.Sakashta Nirgalan 3.Galashoola 4.Swarbhed 5.KasaTimepoint: 3rd,7th

Secondary

MeasureTime frame
1.To study analgesic effect of khadiradi vati using VAS Scale 2.To study anti inflammatory effect of khadiradi vati by examination of throat congestionTimepoint: 3rd,7th

Countries

India

Contacts

Public ContactDr Fizza Sheikh

Shri Ayurved Mahavidyalay Nagpur

drgovind2005@gmail.com9860166089

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026